A Nanoparticle-Lectin Immunoassay Improves Discrimination of Serum CA125 from Malignant and Benign Sources

Kamlesh Gidwani; Kaisa Huhtinen; Henna Kekki; Sandra van Vliet; Johanna Hynninen; Niina Koivuviita; Anti Perheentupa; Matti Poutanen; Annika Auranen; Seija Grenman; Urpo Lamminmaki; Olli Carpen; Yvette van Kooyk; Kim Pettersson

doi:10.1373/clinchem.2016.257691

A Nanoparticle-Lectin Immunoassay Improves Discrimination of Serum CA125 from Malignant and Benign Sources

Kamlesh Gidwani
, Kaisa Huhtinen
, Henna Kekki
, Sandra van Vliet
, Johanna Hynninen
, Niina Koivuviita
, Anti Perheentupa
, Matti Poutanen
, Annika Auranen
, Seija Grenman
, Urpo Lamminmaki
, Olli Carpen
, Yvette van Kooyk
, Kim Pettersson

Research output: Contribution to journal › Article › Academic › peer-review

14 Downloads (Pure)

Original language	English
Pages (from-to)	1390-1400
Journal	Clinical chemistry
Volume	62
Issue number	10
DOIs	https://doi.org/10.1373/clinchem.2016.257691
Publication status	Published - Oct 2016

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

SDG 3 Good Health and Well-being

Access to Document

10.1373/clinchem.2016.257691

A-nanoparticle-lectin-immunoassay-improves-discrimination-of-serum-ca125-from-malignant-and-benign-sources.pdfFinal published version, 1.43 MBLicence: Taverne

Cite this

Gidwani, K., Huhtinen, K., Kekki, H., van Vliet, S., Hynninen, J., Koivuviita, N., Perheentupa, A., Poutanen, M., Auranen, A., Grenman, S., Lamminmaki, U., Carpen, O., van Kooyk, Y., & Pettersson, K. (2016). A Nanoparticle-Lectin Immunoassay Improves Discrimination of Serum CA125 from Malignant and Benign Sources. Clinical chemistry, 62(10), 1390-1400. https://doi.org/10.1373/clinchem.2016.257691

@article{c399c9040f864584a67ecb61c39640e8,

title = "A Nanoparticle-Lectin Immunoassay Improves Discrimination of Serum CA125 from Malignant and Benign Sources",

author = "Kamlesh Gidwani and Kaisa Huhtinen and Henna Kekki and \{van Vliet\}, Sandra and Johanna Hynninen and Niina Koivuviita and Anti Perheentupa and Matti Poutanen and Annika Auranen and Seija Grenman and Urpo Lamminmaki and Olli Carpen and \{van Kooyk\}, Yvette and Kim Pettersson",

year = "2016",

month = oct,

doi = "10.1373/clinchem.2016.257691",

language = "English",

volume = "62",

pages = "1390--1400",

journal = "Clinical chemistry",

issn = "0009-9147",

publisher = "American Association for Clinical Chemistry Inc.",

number = "10",

}

Gidwani, K, Huhtinen, K, Kekki, H, van Vliet, S, Hynninen, J, Koivuviita, N, Perheentupa, A, Poutanen, M, Auranen, A, Grenman, S, Lamminmaki, U, Carpen, O, van Kooyk, Y & Pettersson, K 2016, 'A Nanoparticle-Lectin Immunoassay Improves Discrimination of Serum CA125 from Malignant and Benign Sources', Clinical chemistry, vol. 62, no. 10, pp. 1390-1400. https://doi.org/10.1373/clinchem.2016.257691

TY - JOUR

T1 - A Nanoparticle-Lectin Immunoassay Improves Discrimination of Serum CA125 from Malignant and Benign Sources

AU - Gidwani, Kamlesh

AU - Huhtinen, Kaisa

AU - Kekki, Henna

AU - van Vliet, Sandra

AU - Hynninen, Johanna

AU - Koivuviita, Niina

AU - Perheentupa, Anti

AU - Poutanen, Matti

AU - Auranen, Annika

AU - Grenman, Seija

AU - Lamminmaki, Urpo

AU - Carpen, Olli

AU - van Kooyk, Yvette

AU - Pettersson, Kim

PY - 2016/10

Y1 - 2016/10

U2 - 10.1373/clinchem.2016.257691

DO - 10.1373/clinchem.2016.257691

M3 - Article

C2 - 27540033

SN - 0009-9147

VL - 62

SP - 1390

EP - 1400

JO - Clinical chemistry

JF - Clinical chemistry

IS - 10

ER -